In a bold stride towards combating Amyotrophic Lateral Sclerosis (ALS), Brainstorm Cell Therapeutics has formed a strategic alliance with Minaris Advanced Therapies. Together, they aim to ramp up the manufacture of NurOwn (debamestrocel), an innovative cell therapy under development for ALS patients. This partnership is a decisive move to expedite the production of NurOwn, thereby […]